MRNA
莫德納 Moderna, Inc.
+12.09 (+8.31%)157.72USD11.4M成交股數63.0B市值–本益比(近四季)28.3股價營收比+2.1%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 145M+2% | 389M+260% | 678M-64% | 1.0B+322% | 142M-15% | 108M-96% | 1.9B+2% | 241M-30% | 167M | 2.8B | 1.8B | 344M |
| 營業成本 | 93.0M | 955M | 452M | 207M | 119M | 90.0M | 514M | 115M | 96.0M | 929M | 2.2B | 731M |
| 毛利 | 52.0M+126% | −566M-3244% | 226M-83% | 809M+542% | 23.0M-68% | 18.0M-99% | 1.3B-429% | 126M-133% | 71.0M | 1.9B | −410M | −387M |
| 毛利率 | 35.9% | -145.5% | 33.3% | 79.6% | 16.2% | 16.7% | 72.4% | 52.3% | 42.5% | 67.0% | -22.4% | -112.5% |
| 研發費用 | 651M | 649M | 775M | 801M | 700M | 856M | 1.1B | 1.2B | 1.1B | 1.4B | 1.2B | 1.1B |
| 銷售管理費用 | 216M | 173M | 308M | 268M | 230M | 212M | 281M | 268M | 274M | 470M | 442M | 332M |
| 營業利益 | −815M-10% | −1.4B+32% | −857M+1124% | −260M-81% | −907M-28% | −1.1B-17600% | −70.0M-97% | −1.4B-27% | −1.3B | 6.0M | −2.0B | −1.9B |
| 營業利益率 | -562.1% | -356.8% | -126.4% | -25.6% | -638.7% | -972.2% | -3.8% | -565.6% | -758.1% | 0.2% | -109.9% | -542.7% |
| 稅後淨利 | −782M-5% | −1.3B+38% | −826M-6454% | −200M-84% | −825M-30% | −971M-547% | 13.0M-100% | −1.3B-7% | −1.2B | 217M | −3.6B | −1.4B |
| 淨利率 | -539.3% | -345.2% | -121.8% | -19.7% | -581.0% | -899.1% | 0.7% | -530.7% | -703.6% | 7.7% | -198.3% | -401.2% |
| 稀釋 EPS | -1.97-8% | -3.40+35% | -2.10-7100% | -0.51-85% | -2.13-31% | -2.52-500% | 0.03-100% | -3.33-8% | -3.07 | 0.63 | -9.53 | -3.62 |
| 稀釋股數 | 398M | 395M | 389M | 390M | 388M | 386M | 399M | 384M | 382M | 382M | 381M | 381M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 1.7B | 1.9B | 2.6B | 1.1B | 1.3B | 1.6B | 1.6B | 2.5B | 2.1B | 2.9B | 2.9B | 3.8B |
| 應收帳款 | 17.0M | 71.0M | 184M | 1.0B | 36.0M | 78.0M | 1.6B | 163M | 137M | 892M | 1.9B | 232M |
| 存貨 | 280M | 146M | 153M | 332M | 240M | 128M | 412M | 399M | 295M | 202M | 487M | 715M |
| 總資產 | 11.0B | 11.5B | 12.3B | 12.1B | 12.0B | 12.7B | 15.8B | 15.7B | 16.7B | 18.4B | 19.5B | 21.9B |
| 有息負債 | 591M | 590M | 590M | – | – | – | – | – | – | – | – | – |
| 總負債 | 4.2B | 4.1B | 3.7B | 2.8B | 2.6B | 2.6B | 3.9B | 4.0B | 3.9B | 4.6B | 6.0B | 4.9B |
| 股東權益 | 6.8B | 7.4B | 8.7B | 9.3B | 9.4B | 10.1B | 11.9B | 11.7B | 12.8B | 13.9B | 13.5B | 16.9B |
| 負債比 | 38.3% | 35.5% | 29.9% | 23.1% | 21.7% | 20.8% | 24.5% | 25.3% | 23.4% | 24.8% | 30.8% | 22.6% |
| 淨現金(現金 − 有息負債) | 1.1B | 1.3B | 2.0B | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −630M-39% | – | – | – | −1.0B | – | – | −989M | – | – | – |
| 資本支出 | – | 62.0M | – | – | – | 117M | – | – | 196M | – | – | – |
| 自由現金流 | – | −692M-40% | – | – | – | −1.2B | – | – | −1.2B | – | – | – |
| 折舊攤銷 | 56.0M | 56.0M | 66.0M | 51.0M | 56.0M | 38.0M | 51.0M | 40.0M | 35.0M | 203M | 246M | 90.0M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | 0.00 | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -177.9% | – | – | – | -1,068.5% | – | – | -709.6% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
地區2025 年度 · 1.9B
| 美國 | 1.2B | 61.7% | -32.8% |
|---|---|---|---|
| 其他地區 | 692M | 35.6% | -18.9% |
| 歐洲 | 53.0M | 2.7% | -91.1% |
產品／服務2025 年度 · 2.1B
| COVID19 | 1.8B | 87.4% | -41.3% |
|---|---|---|---|
| Product And Service Other | 126M | 6.1% | -0.8% |
| Stand Ready Manufacturing Revenue | 80.0M | 3.9% | – |
| Grant | 22.0M | 1.1% | -40.5% |
| Collaboration Arrangement Including Arrangements With Affiliate | 13.0M | 0.6% | -72.9% |
| License And Royalty | 11.0M | 0.5% | -73.8% |
| RSV | 8.0M | 0.4% | -68.0% |
| Product Sales 小計 | 1.8B | 87.8% | -41.5% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 1.9B | -39.9% | −2.8B | -145.2% | -7.26 | −2.1B |
| FY2024 | 3.2B | -52.7% | −3.6B | -110.0% | -9.28 | −4.1B |
| FY2023 | 6.8B | -64.4% | −4.7B | -68.8% | -12.33 | −3.8B |
| FY2022 | 19.3B | +4.3% | 8.4B | 43.4% | 20.12 | 4.6B |
| FY2021 | 18.5B | +2200.2% | 12.2B | 66.1% | 28.29 | 13.3B |
| FY2020 | 803M | +1233.7% | −747M | -93.0% | -1.96 | 2.0B |
| FY2019 | 60.2M | -55.4% | −514M | -853.7% | -1.55 | −491M |
| FY2018 | 135M | – | −385M | -284.8% | -4.95 | −437M |